Northern Trust’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-583,069
| Closed | -$39.7M | – | 4786 |
|
|
2022
Q3 | $39.7M | Buy |
583,069
+8,647
| +2% | +$477K | 0.01% | 994 |
|
|
2022
Q2 | $18.4M | Sell |
574,422
-11,975
| -2% | -$351K | ﹤0.01% | 1589 |
|
|
2022
Q1 | $20.3M | Sell |
586,397
-22,881
| -4% | -$684K | ﹤0.01% | 1664 |
|
|
2021
Q4 | $17.8M | Buy |
609,278
+5,115
| +0.8% | +$158K | ﹤0.01% | 1858 |
|
|
2021
Q3 | $15.4M | Sell |
604,163
-30,115
| -5% | -$885K | ﹤0.01% | 1976 |
|
|
2021
Q2 | $22.2M | Buy |
634,278
+336,306
| +113% | +$13.1M | ﹤0.01% | 1812 |
|
|
2021
Q1 | $12.1M | Buy |
297,972
+2,329
| +0.8% | +$107K | ﹤0.01% | 2173 |
|
|
2020
Q4 | $12.8M | Sell |
295,643
-1,932
| -0.6% | -$95.3K | ﹤0.01% | 2088 |
|
|
2020
Q3 | $16.4M | Sell |
297,575
-10,274
| -3% | -$653K | ﹤0.01% | 1773 |
|
|
2020
Q2 | $19.4M | Sell |
307,849
-399,107
| -56% | -$27.4M | ﹤0.01% | 1651 |
|
|
2020
Q1 | $36.1M | Buy |
706,956
+9,246
| +1% | +$619K | 0.01% | 987 |
|
|
2019
Q4 | $55.5M | Sell |
697,710
-22,655
| -3% | -$1.34M | 0.01% | 948 |
|
|
2019
Q3 | $35M | Buy |
720,365
+65,380
| +10% | +$3.41M | 0.01% | 1238 |
|
|
2019
Q2 | $34.5M | Buy |
654,985
+7,402
| +1% | +$425K | 0.01% | 1284 |
|
|
2019
Q1 | $34.3M | Buy |
647,583
+35,447
| +6% | +$1.74M | 0.01% | 1275 |
|
|
2018
Q4 | $25.1M | Sell |
612,136
-9,483
| -2% | -$355K | 0.01% | 1394 |
|
|
2018
Q3 | $23.6M | Buy |
621,619
+18,930
| +3% | +$838K | 0.01% | 1654 |
|
|
2018
Q2 | $27.2M | Buy |
602,689
+121,043
| +25% | +$5.51M | 0.01% | 1531 |
|
|
2018
Q1 | $23.3M | Buy |
481,646
+37,751
| +9% | +$2.11M | 0.01% | 1573 |
|
|
2017
Q4 | $17.5M | Sell |
443,895
-11,153
| -2% | -$417K | ﹤0.01% | 1818 |
|
|
2017
Q3 | $14.1M | Buy |
455,048
+3,277
| +0.7% | +$92.2K | ﹤0.01% | 1974 |
|
|
2017
Q2 | $12.4M | Buy |
451,771
+195,657
| +76% | +$5.82M | ﹤0.01% | 2029 |
|
|
2017
Q1 | $9.44M | Buy |
256,114
+27,506
| +12% | +$693K | ﹤0.01% | 2160 |
|
|
2016
Q4 | $3.3M | Buy |
228,608
+8,460
| +4% | +$149K | ﹤0.01% | 2816 |
|
|
2016
Q3 | $5.08M | Buy |
220,148
+64,583
| +42% | +$1.23M | ﹤0.01% | 2507 |
|
|
2016
Q2 | $2.58M | Buy |
155,565
+79,681
| +105% | +$1.61M | ﹤0.01% | 2897 |
|
|
2016
Q1 | $1.2M | Buy |
75,884
+113
| +0.1% | +$2.01K | ﹤0.01% | 3195 |
|
|
2015
Q4 | $2.45M | Buy |
75,771
+59,775
| +374% | +$2.59M | ﹤0.01% | 2935 |
|
|
2015
Q3 | $674K | Buy |
+15,996
| New | +$755K | ﹤0.01% | 3421 |
|
Other funds holding GBT
Northern Trust's GBT Position: Q4 2022 in Review
Northern Trust sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 583,069 shares — an estimated $39.7M sold.
Northern Trust first reported a position in GBT in Q3 2015 and held it in 29 quarters. The position peaked at $55.5M in Q4 2019. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Northern Trust reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Northern Trust sold 583,069 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $39.7M.
- Northern Trust first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 29 quarters.
- Northern Trust's Global Blood Therapeutics, Inc. position peaked at $55.5M in Q4 2019.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Northern Trust's 13F filing for Q4 2022, filed 13 Feb 2023.